Journals / Turkish Journal of Pediatrics / 2015 / Cilt: 57 - Sayı: 5

Total oxidant status, total antioxidant capacity and ischemia modified albumin levels in children with celiac disease

Pages
498–503
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We also detected that IMA is a marker that shows a correlation with the histopathological stage, and may be used in the diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sayar E, Özdem S, Uzun G, İşlek A, Yılmaz A, Artan R.
📊
Key Findings & Data:Turk J Pediatr 2015; 57: 498-503.
💡
Conclusion & Impact:We also detected that IMA is a marker that shows a correlation with the histopathological stage, and may be used in the diagnosis.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Sayar E, Özdem S, Uzun G, İşlek A, Yılmaz A, Artan R. Total oxidant status, total antioxidant capacity and ischemia modified albumin levels in children with celiac disease. Turk J Pediatr 2015; 57: 498-503. In our study, we aimed to investigate ischemia modified albumin (IMA) as an oxidative stress marker, as well as other oxidant and antioxidant markers that have not been evaluated in children with celiac disease. A total of 37 pediatric patients who were diagnosed with celiac disease (CD) and 29 healthy children were enrolled in this prospective study. We evaluated the IMA, total oxidant status, total antioxidant capacity, sulfhydryl, and advanced oxidation protein products in all of the subjects. We also compared the levels at the time of the diagnosis, and following a gluten-free diet (GFD) in the children with CD. While the IMA and the other oxidant marker levels were significantly higher in the patient group compared to the control group, the antioxidant marker levels were found to be significantly lower in the patient group, compared to the control group. We also determined that the tissue transglutaminase IgA showed a highly positive correlation, and that the IMA showed a moderately positive correlation with the Marsh-Oberhuber histopathological stage. Additionally, the IMA and other oxidant marker levels were significantly lower, while the antioxidant marker levels were significantly higher after the GFD, compared to the pre-diet period. We detected that oxidative stress played a role in the pathogenesis of CD, and that this could be evaluated using oxidative stress markers, which would regress after the GFD. We also detected that IMA is a marker that shows a correlation with the histopathological stage, and may be used in the diagnosis.

🔖

Cite This Article

SAYAR, E., ÖZDEM, S., UZUN, G., İŞLEK, A., YILMAZ, A., ARTAN, R. (2015). Total oxidant status, total antioxidant capacity and ischemia modified albumin levels in children with celiac disease. Turkish Journal of Pediatrics, Cilt: 57 - Sayı: 5, 498–503. https://ajindex.com/articles/412278

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 2012; 367: 2419-2426
  2. Ferretti G, Bachetti T, Masciangelo S, Saturni L. Celiac disease, inflammation and oxidative damage. Nutrients 2012; 4: 243-257
  3. McCord. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163
  4. Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 1997; 29: 3025-3034
  5. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011; 49: 177-184
  6. Kaefer M, Piva SJ, De Carvalho JA, et al. Association between ischemia-modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010; 43: 450-454
  7. Duarte MM, Rocha JB, Moresco RN, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009; 42: 666-671
  8. Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 2008; 22: 1-5
  9. Piva SJ, Duarte MM, Da Cruz IB, et al. Ischemiamodified albumin as an oxidative stress biomarker in obesity. Clin Biochem 2011; 44: 345-347
  10. Awadallah SM, Atoum MF, Nimer NA, Saleh SA. Ischemia modified albumin: an oxidative stress marker in ?-thalassemia major. Clin Chim Acta 2012; 413: 907-910
  11. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-160
  12. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19: 311-315
  13. Bar-Or D, Lau E, Rao N. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia. Ann Emerg Med 1999; 34: 56
  14. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119
  15. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111
  16. Koster JF, Biemon P, Swaak AJ. Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis 1986; 45: 4